MAPT and Alzheimer disease: However, in contrast with tau-PET, plasma p-tau217 provides no regional information on AD pathology, its continuous values are less representative of the full dynamic range of tau pathology and its signal represents a mix of tau and Aβ pathology and is therefore a less tau-specific biomarker20–22.